Psylo

Developer of psychedelic derived therapeutic for mental illness

placeSydney, New South Wales, Australia calendar_todayFounded 2021 groups24 employees language psylo.bio

Registered entities

Investor mix

15 investors on record; lead investors include Main Sequence, Tenmile.

Investor typeCountShare
Venture capital1280%
Other / undisclosed320%
Coming soon